Potential Drug Targets for Neuroregeneration and Repair

Potential Drug Targets for Neuroregeneration and Repair

Unlike the peripheral nervous system (PNS) the adult mammalian central nervous system (CNS) does not spontaneously regenerate after injury. Numerous axon-inhibitory molecules are present in the injured CNS and various strategies for overcoming these obstacles and enhancing CNS regeneration had been experimentally developed. Adult neuroregeneration is a complex process, beyond the common knowled...

Glycosyltransferases as Potential Drug Targets

Copyright: © 2013 Sun XL. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Glycoconjugates, existing as glycoproteins, glycolipids and proteoglycans on cell surface, are involved in many biological processes, s...

Schistosomes--proteomics studies for potential novel vaccines and drug targets.

Schistosomiasis is a major health problem and, despite decades of research, only one effective drug, Praziquantel is currently available. Recent expansion of sequence databases on Schistosoma mansoni and S. japonicum has permitted a wealth of novel proteomic studies on several aspects of the organization and development of the parasite in the human host. This unprecedented accumulation of molec...

micrornas: promising potential targets for cancer treatment

Living scaffolds for neuroregeneration.

Neural tissue engineers are exploiting key mechanisms responsible for neural cell migration and axonal path finding during embryonic development to create living scaffolds for neuroregeneration following injury and disease. These mechanisms involve the combined use of haptotactic, chemotactic, and mechanical cues to direct cell movement and re-growth. Living scaffolds provide these cues through...